Literature DB >> 17006913

Glutamine: a Trojan horse in ammonia neurotoxicity.

Jan Albrecht1, Michael D Norenberg.   

Abstract

Mechanisms involved in hepatic encephalopathy still remain to be defined. Nonetheless, it is well recognized that ammonia is a major factor in its pathogenesis, and that the astrocyte represents a major target of its CNS toxicity. In vivo and in vitro studies have shown that ammonia evokes oxidative/nitrosative stress, mitochondrial abnormalities (the mitochondrial permeability transition, MPT) and astrocyte swelling, a major component of the brain edema associated with fulminant hepatic failure. How ammonia brings about these changes in astrocytes is not well understood. It has long been accepted that the conversion of glutamate to glutamine, catalyzed by glutamine synthetase, a cytoplasmic enzyme largely localized to astrocytes in brain, represented the principal means of cerebral ammonia detoxification. Yet, the "benign" aspect of glutamine synthesis has been questioned. This article highlights evidence that, at elevated levels, glutamine is indeed a noxious agent. We also propose a mechanism by which glutamine executes its toxic effects in astrocytes, the "Trojan horse" hypothesis. Much of the newly synthesized glutamine is subsequently metabolized in mitochondria by phosphate-activated glutaminase, yielding glutamate and ammonia. In this manner, glutamine (the Trojan horse) is transported in excess from the cytoplasm to mitochondria serving as a carrier of ammonia. We propose that it is the glutamine-derived ammonia within mitochondria that interferes with mitochondrial function giving rise to excessive production of free radicals and induction of the MPT, two phenomena known to bring about astrocyte dysfunction, including cell swelling. Future therapeutic approaches might include controlling excessive transport of newly synthesized glutamine to mitochondria and its subsequent hydrolysis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17006913     DOI: 10.1002/hep.21357

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  120 in total

1.  Brain aquaporin-4 in experimental acute liver failure.

Authors:  Kakulavarapu V Rama Rao; Arumugam R Jayakumar; Xiaoying Tong; Kevin M Curtis; Michael D Norenberg
Journal:  J Neuropathol Exp Neurol       Date:  2010-09       Impact factor: 3.685

Review 2.  Role of astrocytes in brain function and disease.

Authors:  Marta Sidoryk-Wegrzynowicz; Michal Wegrzynowicz; Eunsook Lee; Aaron B Bowman; Michael Aschner
Journal:  Toxicol Pathol       Date:  2010-11-12       Impact factor: 1.902

Review 3.  Volume-regulated anion channel--a frenemy within the brain.

Authors:  Alexander A Mongin
Journal:  Pflugers Arch       Date:  2015-12-01       Impact factor: 3.657

Review 4.  Brain edema in acute liver failure: can it be prevented? Can it be treated?

Authors:  Andres T Blei
Journal:  J Hepatol       Date:  2007-02-05       Impact factor: 25.083

5.  Linking binge alcohol-induced neurodamage to brain edema and potential aquaporin-4 upregulation: evidence in rat organotypic brain slice cultures and in vivo.

Authors:  Kumar Sripathirathan; James Brown; Edward J Neafsey; Michael A Collins
Journal:  J Neurotrauma       Date:  2009-02-11       Impact factor: 5.269

Review 6.  Current pathogenetic aspects of hepatic encephalopathy and noncirrhotic hyperammonemic encephalopathy.

Authors:  Halina Cichoż-Lach; Agata Michalak
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

Review 7.  Aquaporin-4 in hepatic encephalopathy.

Authors:  K V Rama Rao; M D Norenberg
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

Review 8.  In vivo studies of brain metabolism in animal models of Hepatic Encephalopathy using ¹H Magnetic Resonance Spectroscopy.

Authors:  Cristina Cudalbu
Journal:  Metab Brain Dis       Date:  2012-12-21       Impact factor: 3.584

9.  Management of hepatic encephalopathy.

Authors:  Jennifer A Frontera
Journal:  Curr Treat Options Neurol       Date:  2014-06       Impact factor: 3.598

10.  Pannexin1 as a novel cerebral target in pathogenesis of hepatic encephalopathy.

Authors:  Papia Mondal; Surendra Kumar Trigun
Journal:  Metab Brain Dis       Date:  2014-05-08       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.